MeSH Tree Structures - 2011

E05 - Investigative Techniques

• Investigative Techniques [E05]
  • Animal Experimentation [E05.017]
    • Animal Use Alternatives [E05.017.080]
      • Animal Testing Alternatives [E05.017.080.100]
    • Rotarod Performance Test [E05.017.449]
    • Vivisection [E05.017.900]
  • Animal Identification Systems [E05.035]
  • Anthropometry [E05.041]
    • Body Weights and Measures [E05.041.124]
      • Body Mass Index [E05.041.124.125]
      • Body Size [E05.041.124.160]
        • Body Height [E05.041.124.160.500]
          • Crown-Rump Length [E05.041.124.160.500.500]
        • Body Weight [E05.041.124.160.750]
          • Birth Weight [E05.041.124.160.750.149]
          • Fetal Weight [E05.041.124.160.750.300]
          • Ideal Body Weight [E05.041.124.160.750.650]
        • Waist Circumference [E05.041.124.160.875]
      • Body Surface Area [E05.041.124.231]
      • Organ Size [E05.041.124.715]
      • Skinfold Thickness [E05.041.124.803]
      • Tumor Burden [E05.041.124.892]
      • Waist-Hip Ratio [E05.041.124.946]
    • Cephalometry [E05.041.250]
    • Odontometry [E05.041.650]
    • Pelvimetry [E05.041.690]
  • Artifacts [E05.047]
  • Autoanalysis [E05.059]
  • Automation, Laboratory [E05.064]
  • Autopsy [E05.070]
  • Biological Assay [E05.091]
    • Limulus Test [E05.091.570]
  • Biomedical Enhancement [E05.104]
    • Genetic Enhancement [E05.104.500]
  • Brain Mapping [E05.132]
  • Calibration [E05.140]
  • Calorimetry [E05.145]
    • Calorimetry, Indirect [E05.145.250]
  • Catheterization [E05.157]
  • Cell Tracking [E05.163]
  • Cementation [E05.170]
  • Centrifugation [E05.181]
    • Ultracentrifugation [E05.181.724]
      • Centrifugation, Density Gradient [E05.181.724.336]
        • Centrifugation, Isopycnic [E05.181.724.336.253]
        • Centrifugation, Zonal [E05.181.724.336.336]
  • Chemistry Techniques, Analytical [E05.196]
    • Activation Analysis [E05.196.039]
      • Neutron Activation Analysis [E05.196.039.564]
    • Binding, Competitive [E05.196.080]
    • Biuret Reaction [E05.196.085]
    • Calorimetry [E05.196.131]
      • Calorimetry, Differential Scanning [E05.196.131.310]
    • Chemical Precipitation [E05.196.150]
      • Flocculation [E05.196.150.347]
        • Flocculation Tests [E05.196.150.347.500]
      • Fractional Precipitation [E05.196.150.519]
      • Immunoprecipitation [E05.196.150.639]
        • Precipitin Tests [E05.196.150.639.500]
    • Chemical Fractionation [E05.196.155]
      • Distillation [E05.196.155.249]
      • Fractionation, Field Flow [E05.196.155.500]
      • Solid Phase Extraction [E05.196.155.800]
        • Solid Phase Microextraction [E05.196.155.800.500]
    • Chromatography [E05.196.181]
      • Chromatography, Gas [E05.196.181.349]
        • Flame Ionization [E05.196.181.349.390]
        • Gas Chromatography-Mass Spectrometry [E05.196.181.349.500]
      • Chromatography, Liquid [E05.196.181.400]
        • Capillary Electrochromatography [E05.196.181.400.150]
        • Chromatography, Affinity [E05.196.181.400.170]
        • Chromatography, Gel [E05.196.181.400.250]
          • Chromatography, Agarose [E05.196.181.400.250.200]
        • Chromatography, High Pressure Liquid [E05.196.181.400.300]
        • Chromatography, Ion Exchange [E05.196.181.400.383]
          • Chromatography, DEAE-Cellulose [E05.196.181.400.383.349]
        • Chromatography, Paper [E05.196.181.400.454]
          • Nucleotide Mapping [E05.196.181.400.454.655]
          • Peptide Mapping [E05.196.181.400.454.720]
        • Chromatography, Reverse-Phase [E05.196.181.400.495]
        • Chromatography, Thin Layer [E05.196.181.400.537]
        • Countercurrent Distribution [E05.196.181.400.555]
      • Chromatography, Micellar Electrokinetic Capillary [E05.196.181.500]
      • Chromatography, Supercritical Fluid [E05.196.181.750]
    • Countercurrent Distribution [E05.196.278]
    • Crystallization [E05.196.300]
    • Crystallography [E05.196.309]
      • Neutron Diffraction [E05.196.309.555]
      • Powder Diffraction [E05.196.309.711]
      • X-Ray Diffraction [E05.196.309.742]
        • Crystallography, X-Ray [E05.196.309.742.225]
    • Desiccation [E05.196.335]
    • Deuterium Exchange Measurement [E05.196.344]
    • Dialysis [E05.196.353]
      • Microdialysis [E05.196.353.500]
    • Differential Thermal Analysis [E05.196.370]
      • Calorimetry, Differential Scanning [E05.196.370.310]
    • Electroosmosis [E05.196.385]
    • Electrophoresis [E05.196.401]
      • Blood Protein Electrophoresis [E05.196.401.076]
      • Blotting, Northern [E05.196.401.095]
      • Blotting, Southern [E05.196.401.114]
      • Blotting, Southwestern [E05.196.401.133]
      • Blotting, Western [E05.196.401.143]
        • Blotting, Far-Western [E05.196.401.143.500]
      • Electrophoresis, Agar Gel [E05.196.401.153]
        • Comet Assay [E05.196.401.153.150]
      • Electrophoresis, Capillary [E05.196.401.190]
        • Capillary Electrochromatography [E05.196.401.190.249]
        • Electrophoresis, Microchip [E05.196.401.190.500]
      • Electrophoresis, Cellulose Acetate [E05.196.401.200]
      • Electrophoresis, Gel, Pulsed-Field [E05.196.401.220]
      • Electrophoresis, Gel, Two-Dimensional [E05.196.401.250]
        • Two-Dimensional Difference Gel Electrophoresis [E05.196.401.250.500]
      • Electrophoresis, Paper [E05.196.401.319]
        • Nucleotide Mapping [E05.196.401.319.670]
        • Peptide Mapping [E05.196.401.319.720]
      • Electrophoresis, Polyacrylamide Gel [E05.196.401.402]
        • Denaturing Gradient Gel Electrophoresis [E05.196.401.402.117]
        • Electrophoresis, Disc [E05.196.401.402.236]
        • Electrophoresis, Gel, Two-Dimensional [E05.196.401.402.250]
          • Two-Dimensional Difference Gel Electrophoresis [E05.196.401.402.250.500]
      • Electrophoresis, Starch Gel [E05.196.401.485]
      • Electrophoretic Mobility Shift Assay [E05.196.401.500]
      • Immunoelectrophoresis [E05.196.401.568]
        • Counterimmunoelectrophoresis [E05.196.401.568.250]
        • Immunoelectrophoresis, Two-Dimensional [E05.196.401.568.520]
      • Isoelectric Focusing [E05.196.401.663]
      • Isotachophoresis [E05.196.401.831]
    • Enzyme Assays [E05.196.427]
      • Clinical Enzyme Tests [E05.196.427.200]
    • Filtration [E05.196.454]
      • Micropore Filters [E05.196.454.403]
      • Ultrafiltration [E05.196.454.807]
        • Hemofiltration [E05.196.454.807.300]
          • Hemodiafiltration [E05.196.454.807.300.300]
    • Flow Injection Analysis [E05.196.460]
    • Glucose Clamp Technique [E05.196.500]
    • Mass Spectrometry [E05.196.566]
      • Gas Chromatography-Mass Spectrometry [E05.196.566.500]
      • Spectrometry, Mass, Electrospray Ionization [E05.196.566.600]
      • Spectrometry, Mass, Fast Atom Bombardment [E05.196.566.750]
      • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization [E05.196.566.755]
      • Spectrometry, Mass, Secondary Ion [E05.196.566.760]
      • Tandem Mass Spectrometry [E05.196.566.880]
    • Microchemistry [E05.196.620]
    • Microchip Analytical Procedures [E05.196.630]
      • Microfluidic Analytical Techniques [E05.196.630.465]
        • Electrophoresis, Microchip [E05.196.630.465.340]
      • Microarray Analysis [E05.196.630.570]
        • Oligonucleotide Array Sequence Analysis [E05.196.630.570.660]
        • Protein Array Analysis [E05.196.630.570.700]
        • Tissue Array Analysis [E05.196.630.570.850]
    • Molecular Imprinting [E05.196.655]
    • Nucleotide Mapping [E05.196.680]
    • Peptide Mapping [E05.196.700]
      • Protein Footprinting [E05.196.700.690]
    • Photometry [E05.196.712]
      • Densitometry [E05.196.712.224]
        • Absorptiometry, Photon [E05.196.712.224.187]
      • Luminescent Measurements [E05.196.712.516]
        • Chemiluminescent Measurements [E05.196.712.516.200]
        • Fluorometry [E05.196.712.516.600]
          • Cytophotometry [E05.196.712.516.600.240]
            • Flow Cytometry [E05.196.712.516.600.240.350]
            • Image Cytometry [E05.196.712.516.600.240.400]
              • Laser Scanning Cytometry [E05.196.712.516.600.240.400.500]
          • Fluorescence Polarization [E05.196.712.516.600.390]
            • Fluorescence Polarization Immunoassay [E05.196.712.516.600.390.350]
          • Fluorescence Recovery After Photobleaching [E05.196.712.516.600.393]
          • Fluorophotometry [E05.196.712.516.600.410]
          • Spectrometry, Fluorescence [E05.196.712.516.600.676]
            • Fluorescence Resonance Energy Transfer [E05.196.712.516.600.676.500]
      • Nephelometry and Turbidimetry [E05.196.712.650]
      • Spectrophotometry [E05.196.712.726]
        • Microspectrophotometry [E05.196.712.726.300]
        • Spectrophotometry, Atomic [E05.196.712.726.551]
        • Spectrophotometry, Infrared [E05.196.712.726.676]
          • Spectroscopy, Fourier Transform Infrared [E05.196.712.726.676.700]
        • Spectrophotometry, Ultraviolet [E05.196.712.726.802]
    • Polarography [E05.196.749]
    • Quartz Crystal Microbalance Techniques [E05.196.778]
    • Refractometry [E05.196.808]
    • Scattering, Radiation [E05.196.822]
      • Neutron Diffraction [E05.196.822.650]
      • Scattering, Small Angle [E05.196.822.830]
      • Spectrum Analysis, Raman [E05.196.822.860]
      • X-Ray Diffraction [E05.196.822.950]
    • Spectrum Analysis [E05.196.867]
      • Circular Dichroism [E05.196.867.151]
      • Dielectric Spectroscopy [E05.196.867.335]
      • Magnetic Resonance Spectroscopy [E05.196.867.519]
        • Electron Spin Resonance Spectroscopy [E05.196.867.519.274]
        • Nuclear Magnetic Resonance, Biomolecular [E05.196.867.519.550]
      • Optical Rotatory Dispersion [E05.196.867.576]
      • Photoelectron Spectroscopy [E05.196.867.618]
      • Pulse Radiolysis [E05.196.867.660]
      • Spectrometry, Fluorescence [E05.196.867.726]
      • Spectrometry, Gamma [E05.196.867.776]
        • Spectroscopy, Mossbauer [E05.196.867.776.751]
      • Spectrometry, X-Ray Emission [E05.196.867.800]
        • Electron Probe Microanalysis [E05.196.867.800.360]
      • Spectrophotometry [E05.196.867.826]
        • Microspectrophotometry [E05.196.867.826.300]
        • Spectrophotometry, Atomic [E05.196.867.826.551]
        • Spectrophotometry, Infrared [E05.196.867.826.676]
          • Spectroscopy, Fourier Transform Infrared [E05.196.867.826.676.700]
        • Spectrophotometry, Ultraviolet [E05.196.867.826.802]
      • Spectroscopy, Electron Energy-Loss [E05.196.867.838]
        • Microscopy, Energy-Filtering Transmission Electron [E05.196.867.838.500]
      • Spectroscopy, Near-Infrared [E05.196.867.851]
      • Spectrum Analysis, Raman [E05.196.867.890]
      • Terahertz Spectroscopy [E05.196.867.945]
      • X-Ray Absorption Spectroscopy [E05.196.867.972]
    • Spin Trapping [E05.196.885]
    • Surface Plasmon Resonance [E05.196.890]
    • Thermogravimetry [E05.196.904]
    • Titrimetry [E05.196.922]
      • Colorimetry [E05.196.922.250]
      • Conductometry [E05.196.922.500]
      • Potentiometry [E05.196.922.750]
    • Ultracentrifugation [E05.196.941]
      • Centrifugation, Density Gradient [E05.196.941.336]
        • Centrifugation, Isopycnic [E05.196.941.336.253]
        • Centrifugation, Zonal [E05.196.941.336.419]
  • Click Chemistry [E05.198]
  • Clinical Laboratory Techniques [E05.200]
    • Culture Techniques [E05.200.249]
      • Cell Culture Techniques [E05.200.249.249]
      • Coculture Techniques [E05.200.249.374]
      • Diffusion Chambers, Culture [E05.200.249.437]
      • Embryo Culture Techniques [E05.200.249.468]
      • Organ Culture Techniques [E05.200.249.484]
      • Plant Somatic Embryogenesis Techniques [E05.200.249.550]
      • Tissue Culture Techniques [E05.200.249.617]
      • Tissue Engineering [E05.200.249.750]
    • Cytological Techniques [E05.200.500]
      • Autoradiography [E05.200.500.105]
      • Cell Count [E05.200.500.195]
        • Blood Cell Count [E05.200.500.195.107]
          • Erythrocyte Count [E05.200.500.195.107.330]
            • Reticulocyte Count [E05.200.500.195.107.330.725]
          • Leukocyte Count [E05.200.500.195.107.595]
            • Lymphocyte Count [E05.200.500.195.107.595.500]
              • CD4 Lymphocyte Count [E05.200.500.195.107.595.500.150]
                • CD4-CD8 Ratio [E05.200.500.195.107.595.500.150.160]
          • Platelet Count [E05.200.500.195.107.740]
        • Sperm Count [E05.200.500.195.870]
      • Cell Fractionation [E05.200.500.251]
      • Cell Fusion [E05.200.500.307]
      • Cell Migration Assays [E05.200.500.335]
        • Cell Migration Assays, Leukocyte [E05.200.500.335.500]
        • Cell Migration Assays, Macrophage [E05.200.500.335.750]
        • Skin Window Technique [E05.200.500.335.875]
      • Cell Separation [E05.200.500.363]
        • Cytapheresis [E05.200.500.363.285]
          • Leukapheresis [E05.200.500.363.285.570]
          • Plateletpheresis [E05.200.500.363.285.790]
        • Immunomagnetic Separation [E05.200.500.363.400]
        • Leukocyte Reduction Procedures [E05.200.500.363.540]
      • Cell Tracking [E05.200.500.373]
      • Colony-Forming Units Assay [E05.200.500.383]
        • Tumor Stem Cell Assay [E05.200.500.383.910]
      • Cytogenetic Analysis [E05.200.500.385]
        • Chromosome Banding [E05.200.500.385.130]
        • Mitotic Index [E05.200.500.385.500]
      • Cytophotometry [E05.200.500.386]
        • Flow Cytometry [E05.200.500.386.350]
        • Image Cytometry [E05.200.500.386.400]
          • Laser Scanning Cytometry [E05.200.500.386.400.500]
      • Diffusion Chambers, Culture [E05.200.500.387]
      • Drug Screening Assays, Antitumor [E05.200.500.388]
        • Tumor Stem Cell Assay [E05.200.500.388.930]
      • Electroporation [E05.200.500.410]
        • Electrochemotherapy [E05.200.500.410.500]
      • Enzyme-Linked Immunospot Assay [E05.200.500.508]
      • Histocytochemistry [E05.200.500.607]
        • Immunohistochemistry [E05.200.500.607.512]
        • Periodic Acid-Schiff Reaction [E05.200.500.607.790]
        • Prussian Blue Reaction [E05.200.500.607.810]
      • Histocytological Preparation Techniques [E05.200.500.620]
        • Microtomy [E05.200.500.620.530]
          • Cryoultramicrotomy [E05.200.500.620.530.160]
            • Frozen Sections [E05.200.500.620.530.160.260]
        • Replica Techniques [E05.200.500.620.620]
          • Corrosion Casting [E05.200.500.620.620.150]
          • Freeze Fracturing [E05.200.500.620.620.260]
            • Freeze Etching [E05.200.500.620.620.260.400]
        • Staining and Labeling [E05.200.500.620.670]
          • Chromosome Banding [E05.200.500.620.670.130]
          • In Situ Hybridization [E05.200.500.620.670.325]
            • In Situ Hybridization, Fluorescence [E05.200.500.620.670.325.350]
              • Chromosome Painting [E05.200.500.620.670.325.350.125]
            • Primed In Situ Labeling [E05.200.500.620.670.325.680]
          • Negative Staining [E05.200.500.620.670.520]
          • Neuroanatomical Tract-Tracing Techniques [E05.200.500.620.670.570]
          • Periodic Acid-Schiff Reaction [E05.200.500.620.670.620]
          • Prussian Blue Reaction [E05.200.500.620.670.660]
          • Shadowing (Histology) [E05.200.500.620.670.770]
          • Silver Staining [E05.200.500.620.670.780]
        • Tissue Embedding [E05.200.500.620.720]
          • Paraffin Embedding [E05.200.500.620.720.610]
          • Plastic Embedding [E05.200.500.620.720.640]
        • Tissue Preservation [E05.200.500.620.760]
          • Cryopreservation [E05.200.500.620.760.160]
            • Freeze Drying [E05.200.500.620.760.160.260]
              • Freeze Substitution [E05.200.500.620.760.160.260.270]
          • Tissue Fixation [E05.200.500.620.760.720]
      • Karyometry [E05.200.500.695]
      • Patch-Clamp Techniques [E05.200.500.800]
      • Single-Cell Analysis [E05.200.500.900]
    • Histological Techniques [E05.200.750]
      • Autoradiography [E05.200.750.132]
      • Bone Demineralization Technique [E05.200.750.210]
      • Decalcification Technique [E05.200.750.288]
      • Histocytochemistry [E05.200.750.551]
        • Immunohistochemistry [E05.200.750.551.512]
          • Fluorescent Antibody Technique [E05.200.750.551.512.240]
            • Fluorescent Antibody Technique, Direct [E05.200.750.551.512.240.300]
            • Fluorescent Antibody Technique, Indirect [E05.200.750.551.512.240.310]
        • Periodic Acid-Schiff Reaction [E05.200.750.551.790]
        • Prussian Blue Reaction [E05.200.750.551.810]
      • Histocytological Preparation Techniques [E05.200.750.600]
        • Microdissection [E05.200.750.600.520]
        • Microtomy [E05.200.750.600.530]
          • Cryoultramicrotomy [E05.200.750.600.530.160]
            • Frozen Sections [E05.200.750.600.530.160.260]
        • Replica Techniques [E05.200.750.600.620]
          • Corrosion Casting [E05.200.750.600.620.150]
          • Freeze Fracturing [E05.200.750.600.620.260]
            • Freeze Etching [E05.200.750.600.620.260.400]
        • Staining and Labeling [E05.200.750.600.670]
          • Chromosome Banding [E05.200.750.600.670.130]
          • In Situ Hybridization [E05.200.750.600.670.325]
            • In Situ Hybridization, Fluorescence [E05.200.750.600.670.325.350]
              • Chromosome Painting [E05.200.750.600.670.325.350.125]
            • Primed In Situ Labeling [E05.200.750.600.670.325.680]
          • Negative Staining [E05.200.750.600.670.520]
          • Neuroanatomical Tract-Tracing Techniques [E05.200.750.600.670.570]
          • Periodic Acid-Schiff Reaction [E05.200.750.600.670.620]
          • Prussian Blue Reaction [E05.200.750.600.670.660]
          • Shadowing (Histology) [E05.200.750.600.670.770]
          • Silver Staining [E05.200.750.600.670.780]
        • Tissue Embedding [E05.200.750.600.720]
          • Paraffin Embedding [E05.200.750.600.720.610]
          • Plastic Embedding [E05.200.750.600.720.640]
        • Tissue Preservation [E05.200.750.600.760]
          • Cryopreservation [E05.200.750.600.760.160]
            • Freeze Drying [E05.200.750.600.760.160.260]
              • Freeze Substitution [E05.200.750.600.760.160.260.270]
          • Tissue Fixation [E05.200.750.600.760.720]
    • Microbiological Techniques [E05.200.875]
      • Bacteriological Techniques [E05.200.875.150]
        • Bacterial Load [E05.200.875.150.115]
        • Bacterial Typing Techniques [E05.200.875.150.125]
          • Bacteriophage Typing [E05.200.875.150.125.150]
          • Molecular Typing [E05.200.875.150.125.457]
            • Multilocus Sequence Typing [E05.200.875.150.125.457.500]
          • Ribotyping [E05.200.875.150.125.765]
          • Serotyping [E05.200.875.150.125.890]
        • Limulus Test [E05.200.875.150.570]
      • Colony Count, Microbial [E05.200.875.220]
        • Bacterial Load [E05.200.875.220.115]
      • Microbial Sensitivity Tests [E05.200.875.595]
        • Disk Diffusion Antimicrobial Tests [E05.200.875.595.399]
        • Serum Bactericidal Test [E05.200.875.595.800]
      • Mycological Typing Techniques [E05.200.875.610]
      • Serial Passage [E05.200.875.837]
      • Viral Load [E05.200.875.950]
      • Virus Cultivation [E05.200.875.970]
        • Plaque Assay [E05.200.875.970.790]
      • Virus Inactivation [E05.200.875.977]
      • Xenodiagnosis [E05.200.875.985]
    • Molecular Diagnostic Techniques [E05.200.880]
    • Parasitic Sensitivity Tests [E05.200.940]
  • Combinatorial Chemistry Techniques [E05.205]
  • Constriction [E05.225]
  • Containment of Biohazards [E05.235]
  • Decision Support Techniques [E05.245]
    • Data Interpretation, Statistical [E05.245.380]
  • Dermatoglyphics [E05.256]
  • Diet [E05.272]
    • Diet, Atherogenic [E05.272.260]
    • Diet, Cariogenic [E05.272.385]
    • Fasting [E05.272.549]
  • Diffusion Tensor Imaging [E05.278]
  • Dilatation [E05.284]
  • Drug Discovery [E05.295]
    • Drug Design [E05.295.500]
    • Drug Evaluation, Preclinical [E05.295.750]
  • Electrochemical Techniques [E05.301]
    • Conductometry [E05.301.160]
    • Electrolysis [E05.301.250]
      • Electroplating [E05.301.250.348]
    • Electroosmosis [E05.301.270]
    • Electrophoresis [E05.301.300]
      • Blood Protein Electrophoresis [E05.301.300.049]
      • Blotting, Northern [E05.301.300.074]
      • Blotting, Southern [E05.301.300.087]
      • Blotting, Southwestern [E05.301.300.093]
      • Blotting, Western [E05.301.300.096]
        • Blotting, Far-Western [E05.301.300.096.500]
      • Electrophoresis, Agar Gel [E05.301.300.100]
        • Comet Assay [E05.301.300.100.150]
      • Electrophoresis, Capillary [E05.301.300.190]
        • Capillary Electrochromatography [E05.301.300.190.500]
      • Electrophoresis, Cellulose Acetate [E05.301.300.200]
      • Electrophoresis, Gel, Pulsed-Field [E05.301.300.220]
      • Electrophoresis, Gel, Two-Dimensional [E05.301.300.230]
        • Two-Dimensional Difference Gel Electrophoresis [E05.301.300.230.500]
      • Electrophoresis, Paper [E05.301.300.236]
      • Electrophoresis, Polyacrylamide Gel [E05.301.300.319]
        • Denaturing Gradient Gel Electrophoresis [E05.301.300.319.201]
        • Electrophoresis, Disc [E05.301.300.319.403]
        • Electrophoresis, Gel, Two-Dimensional [E05.301.300.319.450]
          • Two-Dimensional Difference Gel Electrophoresis [E05.301.300.319.450.500]
      • Electrophoresis, Starch Gel [E05.301.300.402]
      • Immunoelectrophoresis [E05.301.300.568]
        • Counterimmunoelectrophoresis [E05.301.300.568.250]
        • Immunoelectrophoresis, Two-Dimensional [E05.301.300.568.520]
      • Iontophoresis [E05.301.300.575]
      • Isoelectric Focusing [E05.301.300.663]
        • Isoelectric Point [E05.301.300.663.500]
      • Isotachophoresis [E05.301.300.831]
    • Electroporation [E05.301.500]
      • Electrochemotherapy [E05.301.500.500]
    • Polarography [E05.301.700]
    • Potentiometry [E05.301.710]
  • Embryo Research [E05.313]
    • Research Embryo Creation [E05.313.750]
  • Endpoint Determination [E05.315]
  • Epidemiologic Methods [E05.318]
    • Contact Tracing [E05.318.270]
    • Data Collection [E05.318.308]
      • Geriatric Assessment [E05.318.308.225]
      • Health Surveys [E05.318.308.250]
        • Behavioral Risk Factor Surveillance System [E05.318.308.250.149]
        • Dental Health Surveys [E05.318.308.250.300]
          • Dental Plaque Index [E05.318.308.250.300.300]
          • DMF Index [E05.318.308.250.300.350]
          • Oral Hygiene Index [E05.318.308.250.300.675]
          • Periodontal Index [E05.318.308.250.300.725]
        • Health Status Indicators [E05.318.308.250.475]
          • APACHE [E05.318.308.250.475.365]
          • Severity of Illness Index [E05.318.308.250.475.547]
            • Karnofsky Performance Status [E05.318.308.250.475.547.500]
          • Sickness Impact Profile [E05.318.308.250.475.730]
        • Mass Screening [E05.318.308.250.580]
          • Anonymous Testing [E05.318.308.250.580.174]
          • Mass Chest X-Ray [E05.318.308.250.580.510]
          • Multiphasic Screening [E05.318.308.250.580.560]
          • Neonatal Screening [E05.318.308.250.580.580]
          • Vision Screening [E05.318.308.250.580.925]
        • Nutrition Surveys [E05.318.308.250.600]
          • Diet Surveys [E05.318.308.250.600.350]
        • Population Surveillance [E05.318.308.250.700]
          • Sentinel Surveillance [E05.318.308.250.700.650]
      • Health Care Surveys [E05.318.308.335]
      • Interviews as Topic [E05.318.308.420]
        • Focus Groups [E05.318.308.420.200]
      • Lot Quality Assurance Sampling [E05.318.308.461]
      • Narration [E05.318.308.502]
      • Nutrition Assessment [E05.318.308.585]
        • Nutrition Surveys [E05.318.308.585.550]
          • Diet Surveys [E05.318.308.585.550.350]
      • Questionnaires [E05.318.308.750]
        • Self Report [E05.318.308.750.500]
      • Records as Topic [E05.318.308.940]
        • Birth Certificates [E05.318.308.940.250]
        • Death Certificates [E05.318.308.940.350]
        • Dental Records [E05.318.308.940.375]
        • Hospital Records [E05.318.308.940.425]
        • Medical Records [E05.318.308.940.968]
          • Health Records, Personal [E05.318.308.940.968.249]
          • Medical Record Linkage [E05.318.308.940.968.500]
          • Medical Records, Problem-Oriented [E05.318.308.940.968.550]
          • Medical Records Systems, Computerized [E05.318.308.940.968.625]
            • Electronic Health Records [E05.318.308.940.968.625.500]
          • Trauma Severity Indices [E05.318.308.940.968.875]
            • Abbreviated Injury Scale [E05.318.308.940.968.875.125]
            • Glasgow Coma Scale [E05.318.308.940.968.875.250]
            • Glasgow Outcome Scale [E05.318.308.940.968.875.260]
            • Injury Severity Score [E05.318.308.940.968.875.500]
        • Nursing Records [E05.318.308.940.984]
      • Registries [E05.318.308.970]
        • SEER Program [E05.318.308.970.725]
      • Vital Statistics [E05.318.308.985]
        • Life Expectancy [E05.318.308.985.450]
        • Life Tables [E05.318.308.985.475]
        • Morbidity [E05.318.308.985.525]
          • Basic Reproduction Number [E05.318.308.985.525.080]
          • Incidence [E05.318.308.985.525.375]
          • Prevalence [E05.318.308.985.525.750]
        • Mortality [E05.318.308.985.550]
          • Cause of Death [E05.318.308.985.550.250]
          • Child Mortality [E05.318.308.985.550.287]
          • Fatal Outcome [E05.318.308.985.550.325]
          • Fetal Mortality [E05.318.308.985.550.362]
          • Hospital Mortality [E05.318.308.985.550.400]
          • Infant Mortality [E05.318.308.985.550.475]
          • Maternal Mortality [E05.318.308.985.550.500]
          • Perinatal Mortality [E05.318.308.985.550.700]
          • Survival Rate [E05.318.308.985.550.900]
        • Pregnancy Rate [E05.318.308.985.775]
          • Birth Rate [E05.318.308.985.775.500]
    • Disease Notification [E05.318.362]
    • Molecular Epidemiology [E05.318.416]
      • Genome-Wide Association Study [E05.318.416.249]
      • Mendelian Randomization Analysis [E05.318.416.500]
    • Sentinel Surveillance [E05.318.650]
    • Statistics as Topic [E05.318.740]
      • Actuarial Analysis [E05.318.740.100]
        • Life Tables [E05.318.740.100.500]
          • Quality-Adjusted Life Years [E05.318.740.100.500.700]
      • Analysis of Variance [E05.318.740.150]
        • Multivariate Analysis [E05.318.740.150.500]
      • Area Under Curve [E05.318.740.200]
      • Biometry [E05.318.740.225]
        • Biometric Identification [E05.318.740.225.500]
          • DNA Fingerprinting [E05.318.740.225.500.500]
      • Biostatistics [E05.318.740.237]
      • Cluster Analysis [E05.318.740.250]
        • Small-Area Analysis [E05.318.740.250.675]
        • Space-Time Clustering [E05.318.740.250.700]
      • Confidence Intervals [E05.318.740.275]
      • Data Interpretation, Statistical [E05.318.740.300]
      • Discriminant Analysis [E05.318.740.350]
      • Factor Analysis, Statistical [E05.318.740.400]
      • Matched-Pair Analysis [E05.318.740.475]
      • Models, Statistical [E05.318.740.500]
        • Likelihood Functions [E05.318.740.500.475]
        • Linear Models [E05.318.740.500.500]
        • Logistic Models [E05.318.740.500.525]
        • Models, Economic [E05.318.740.500.600]
          • Models, Econometric [E05.318.740.500.600.500]
        • Nomograms [E05.318.740.500.625]
        • Proportional Hazards Models [E05.318.740.500.700]
      • Monte Carlo Method [E05.318.740.525]
      • Principal Component Analysis [E05.318.740.562]
      • Probability [E05.318.740.600]
        • Bayes Theorem [E05.318.740.600.200]
        • Likelihood Functions [E05.318.740.600.400]
        • Markov Chains [E05.318.740.600.500]
        • Odds Ratio [E05.318.740.600.600]
        • Position-Specific Scoring Matrices [E05.318.740.600.650]
        • Propensity Score [E05.318.740.600.675]
        • Proportional Hazards Models [E05.318.740.600.700]
        • Risk [E05.318.740.600.800]
          • Logistic Models [E05.318.740.600.800.450]
          • Risk Assessment [E05.318.740.600.800.715]
          • Risk Factors [E05.318.740.600.800.725]
        • Uncertainty [E05.318.740.600.900]
      • Regression Analysis [E05.318.740.750]
        • Least-Squares Analysis [E05.318.740.750.400]
        • Linear Models [E05.318.740.750.425]
        • Logistic Models [E05.318.740.750.450]
        • Proportional Hazards Models [E05.318.740.750.725]
      • Sensitivity and Specificity [E05.318.740.872]
        • Limit of Detection [E05.318.740.872.374]
        • ROC Curve [E05.318.740.872.750]
      • Statistical Distributions [E05.318.740.994]
        • Binomial Distribution [E05.318.740.994.250]
        • Chi-Square Distribution [E05.318.740.994.300]
        • Normal Distribution [E05.318.740.994.500]
        • Poisson Distribution [E05.318.740.994.750]
      • Statistics, Nonparametric [E05.318.740.995]
      • Stochastic Processes [E05.318.740.996]
        • Markov Chains [E05.318.740.996.500]
      • Survival Analysis [E05.318.740.998]
        • Disease-Free Survival [E05.318.740.998.300]
        • Kaplan-Meier Estimate [E05.318.740.998.650]
        • Proportional Hazards Models [E05.318.740.998.825]
    • Epidemiologic Study Characteristics as Topic [E05.318.760]
      • Epidemiologic Studies [E05.318.760.500]
        • Case-Control Studies [E05.318.760.500.500]
          • Retrospective Studies [E05.318.760.500.500.500]
        • Cohort Studies [E05.318.760.500.750]
          • Longitudinal Studies [E05.318.760.500.750.500]
            • Follow-Up Studies [E05.318.760.500.750.500.350]
            • Prospective Studies [E05.318.760.500.750.500.650]
          • Retrospective Studies [E05.318.760.500.750.750]
        • Cross-Sectional Studies [E05.318.760.500.875]
        • Seroepidemiologic Studies [E05.318.760.500.950]
          • HIV Seroprevalence [E05.318.760.500.950.375]
      • Clinical Trials as Topic [E05.318.760.535]
        • Clinical Trials, Phase I as Topic [E05.318.760.535.200]
        • Clinical Trials, Phase II as Topic [E05.318.760.535.210]
        • Clinical Trials, Phase III as Topic [E05.318.760.535.220]
        • Clinical Trials, Phase IV as Topic [E05.318.760.535.230]
        • Controlled Clinical Trials as Topic [E05.318.760.535.365]
          • Randomized Controlled Trials as Topic [E05.318.760.535.365.500]
        • Multicenter Studies as Topic [E05.318.760.535.500]
      • Feasibility Studies [E05.318.760.550]
      • Intervention Studies [E05.318.760.565]
      • Pilot Projects [E05.318.760.750]
      • Sampling Studies [E05.318.760.875]
      • Twin Studies as Topic [E05.318.760.900]
    • Epidemiologic Research Design [E05.318.780]
      • Control Groups [E05.318.780.074]
      • Cross-Over Studies [E05.318.780.150]
      • Double-Blind Method [E05.318.780.300]
      • Genome-Wide Association Study [E05.318.780.392]
      • Lost to Follow-Up [E05.318.780.438]
      • Matched-Pair Analysis [E05.318.780.485]
      • Meta-Analysis as Topic [E05.318.780.500]
      • Random Allocation [E05.318.780.700]
      • Reproducibility of Results [E05.318.780.725]
      • Sample Size [E05.318.780.762]
      • Sensitivity and Specificity [E05.318.780.800]
        • Predictive Value of Tests [E05.318.780.800.650]
        • ROC Curve [E05.318.780.800.750]
      • Single-Blind Method [E05.318.780.850]
  • Equipment Design [E05.320]
    • Orthodontic Appliance Design [E05.320.274]
    • Prosthesis Design [E05.320.550]
      • Prosthesis Coloring [E05.320.550.550]
  • Equipment Failure [E05.325]
    • Equipment Failure Analysis [E05.325.192]
    • Intrauterine Device Migration [E05.325.578]
      • Intrauterine Device Expulsion [E05.325.578.500]
    • Prosthesis Failure [E05.325.771]
  • Equipment Reuse [E05.328]
  • Equipment Safety [E05.330]
  • Ergometry [E05.333]
    • Exercise Test [E05.333.250]
  • Euthanasia, Animal [E05.335]
  • Evaluation Studies as Topic [E05.337]
    • Clinical Trials as Topic [E05.337.250]
      • Clinical Trials, Phase I as Topic [E05.337.250.200]
      • Clinical Trials, Phase II as Topic [E05.337.250.210]
      • Clinical Trials, Phase III as Topic [E05.337.250.220]
      • Clinical Trials, Phase IV as Topic [E05.337.250.230]
      • Controlled Clinical Trials as Topic [E05.337.250.365]
        • Randomized Controlled Trials as Topic [E05.337.250.365.500]
      • Early Termination of Clinical Trials [E05.337.250.432]
      • Multicenter Studies as Topic [E05.337.250.500]
    • Device Approval [E05.337.275]
      • Diagnostic Test Approval [E05.337.275.500]
    • Drug Approval [E05.337.300]
      • Compassionate Use Trials [E05.337.300.199]
      • Investigational New Drug Application [E05.337.300.400]
    • Drug Evaluation [E05.337.425]
    • Drug Evaluation, Preclinical [E05.337.550]
      • Drug Screening Assays, Antitumor [E05.337.550.200]
        • Tumor Stem Cell Assay [E05.337.550.200.800]
        • Xenograft Model Antitumor Assays [E05.337.550.200.900]
          • Subrenal Capsule Assay [E05.337.550.200.900.830]
      • Microbial Sensitivity Tests [E05.337.550.400]
        • Serum Bactericidal Test [E05.337.550.400.800]
      • Parasitic Sensitivity Tests [E05.337.550.700]
    • Feasibility Studies [E05.337.675]
    • Pilot Projects [E05.337.737]
    • Product Surveillance, Postmarketing [E05.337.800]
      • Adverse Drug Reaction Reporting Systems [E05.337.800.120]
      • Clinical Trials, Phase IV as Topic [E05.337.800.200]
    • Program Evaluation [E05.337.820]
    • Reproducibility of Results [E05.337.851]
    • Validation Studies as Topic [E05.337.925]
  • Fetal Research [E05.349]
  • Finite Element Analysis [E05.355]
  • Food Analysis [E05.362]
  • Fourier Analysis [E05.377]
  • Genetic Techniques [E05.393]
    • Chromatin Immunoprecipitation [E05.393.170]
    • Chromosome Mapping [E05.393.183]
      • Chromosome Walking [E05.393.183.250]
      • Physical Chromosome Mapping [E05.393.183.620]
        • Contig Mapping [E05.393.183.620.160]
        • Radiation Hybrid Mapping [E05.393.183.620.405]
        • Restriction Mapping [E05.393.183.620.650]
          • Optical Restriction Mapping [E05.393.183.620.650.500]
    • Cloning, Molecular [E05.393.220]
      • Artificial Gene Fusion [E05.393.220.250]
      • Two-Hybrid System Techniques [E05.393.220.870]
    • Cloning, Organism [E05.393.240]
    • Contig Mapping [E05.393.260]
    • Crosses, Genetic [E05.393.281]
      • Genetic Complementation Test [E05.393.281.526]
    • Cytogenetic Analysis [E05.393.285]
      • Chromosome Banding [E05.393.285.130]
      • Comparative Genomic Hybridization [E05.393.285.240]
      • In Situ Hybridization, Fluorescence [E05.393.285.350]
        • Chromosome Painting [E05.393.285.350.125]
          • Spectral Karyotyping [E05.393.285.350.125.800]
      • Karyotyping [E05.393.285.475]
        • Spectral Karyotyping [E05.393.285.475.800]
      • Sex Determination Analysis [E05.393.285.830]
    • DNA Fingerprinting [E05.393.290]
      • Amplified Fragment Length Polymorphism Analysis [E05.393.290.382]
      • DNA Contamination [E05.393.290.573]
      • Ribotyping [E05.393.290.765]
    • DNA Footprinting [E05.393.300]
    • Gene Expression Profiling [E05.393.332]
    • Gene Targeting [E05.393.335]
      • Gene Knock-In Techniques [E05.393.335.249]
      • Gene Knockdown Techniques [E05.393.335.500]
      • Gene Knockout Techniques [E05.393.335.750]
    • Gene Transfer Techniques [E05.393.350]
      • Biolistics [E05.393.350.100]
      • Transduction, Genetic [E05.393.350.800]
      • Transfection [E05.393.350.810]
        • Transformation, Bacterial [E05.393.350.810.500]
    • Genetic Association Studies [E05.393.385]
      • Genome-Wide Association Study [E05.393.385.500]
    • Genetic Engineering [E05.393.420]
      • Directed Molecular Evolution [E05.393.420.175]
      • DNA Shuffling [E05.393.420.238]
      • Gene Therapy [E05.393.420.301]
        • Targeted Gene Repair [E05.393.420.301.500]
      • Genetic Enhancement [E05.393.420.451]
      • Protein Engineering [E05.393.420.601]
        • Amino Acid Substitution [E05.393.420.601.035]
        • Mutagenesis, Insertional [E05.393.420.601.550]
        • Mutagenesis, Site-Directed [E05.393.420.601.575]
          • Targeted Gene Repair [E05.393.420.601.575.500]
      • Sex Preselection [E05.393.420.890]
    • Genetic Testing [E05.393.435]
    • Heterozygote Detection [E05.393.450]
    • In Situ Nick-End Labeling [E05.393.475]
    • Molecular Diagnostic Techniques [E05.393.520]
      • Comparative Genomic Hybridization [E05.393.520.500]
    • Molecular Epidemiology [E05.393.522]
      • Genome-Wide Association Study [E05.393.522.500]
    • Molecular Probe Techniques [E05.393.525]
      • Biotinylation [E05.393.525.085]
      • Blotting, Northern [E05.393.525.100]
      • Blotting, Southern [E05.393.525.150]
      • Blotting, Southwestern [E05.393.525.225]
      • Blotting, Western [E05.393.525.262]
        • Blotting, Far-Western [E05.393.525.262.500]
      • Branched DNA Signal Amplification Assay [E05.393.525.300]
      • Oligonucleotide Array Sequence Analysis [E05.393.525.640]
      • Protein Array Analysis [E05.393.525.680]
      • Random Amplified Polymorphic DNA Technique [E05.393.525.700]
      • Two-Hybrid System Techniques [E05.393.525.870]
    • Molecular Typing [E05.393.542]
      • DNA Barcoding, Taxonomic [E05.393.542.249]
      • Multilocus Sequence Typing [E05.393.542.500]
    • Mutagenicity Tests [E05.393.560]
      • Comet Assay [E05.393.560.150]
      • Micronucleus Tests [E05.393.560.598]
    • Nuclear Transfer Techniques [E05.393.580]
    • Nuclease Protection Assays [E05.393.600]
      • DNA Footprinting [E05.393.600.300]
    • Nucleic Acid Amplification Techniques [E05.393.620]
      • Ligase Chain Reaction [E05.393.620.311]
      • Polymerase Chain Reaction [E05.393.620.500]
        • Amplified Fragment Length Polymorphism Analysis [E05.393.620.500.324]
        • Primed In Situ Labeling [E05.393.620.500.650]
        • Random Amplified Polymorphic DNA Technique [E05.393.620.500.687]
        • Reverse Transcriptase Polymerase Chain Reaction [E05.393.620.500.725]
      • Self-Sustained Sequence Replication [E05.393.620.700]
    • Nucleic Acid Denaturation [E05.393.640]
    • Nucleic Acid Hybridization [E05.393.661]
      • Branched DNA Signal Amplification Assay [E05.393.661.124]
      • Comparative Genomic Hybridization [E05.393.661.187]
      • Heteroduplex Analysis [E05.393.661.250]
      • In Situ Hybridization [E05.393.661.475]
        • In Situ Hybridization, Fluorescence [E05.393.661.475.350]
          • Chromosome Painting [E05.393.661.475.350.125]
            • Spectral Karyotyping [E05.393.661.475.350.125.800]
        • Primed In Situ Labeling [E05.393.661.475.680]
      • Oligonucleotide Array Sequence Analysis [E05.393.661.640]
    • Pedigree [E05.393.673]
    • Restriction Mapping [E05.393.712]
      • Optical Restriction Mapping [E05.393.712.500]
    • Sequence Alignment [E05.393.751]
    • Sequence Analysis [E05.393.760]
      • High-Throughput Nucleotide Sequencing [E05.393.760.319]
      • Molecular Sequence Annotation [E05.393.760.479]
      • Oligonucleotide Array Sequence Analysis [E05.393.760.640]
        • Genome-Wide Association Study [E05.393.760.640.500]
      • Position-Specific Scoring Matrices [E05.393.760.670]
      • Sequence Analysis, DNA [E05.393.760.700]
        • DNA Barcoding, Taxonomic [E05.393.760.700.149]
        • DNA Contamination [E05.393.760.700.224]
        • DNA Mutational Analysis [E05.393.760.700.300]
        • Multilocus Sequence Typing [E05.393.760.700.650]
      • Sequence Analysis, Protein [E05.393.760.705]
        • Peptide Mapping [E05.393.760.705.685]
          • Protein Footprinting [E05.393.760.705.685.690]
      • Sequence Analysis, RNA [E05.393.760.710]
  • Hardness Tests [E05.417]
  • Human Experimentation [E05.445]
    • Autoexperimentation [E05.445.100]
    • Nontherapeutic Human Experimentation [E05.445.750]
    • Therapeutic Human Experimentation [E05.445.875]
  • Immersion [E05.466]
  • Immobilization [E05.472]
    • Restraint, Physical [E05.472.760]
      • Hindlimb Suspension [E05.472.760.370]
  • Immunologic Techniques [E05.478]
    • Immunization [E05.478.550]
      • Immunization, Passive [E05.478.550.520]
        • Adoptive Transfer [E05.478.550.520.050]
          • Immunotherapy, Adoptive [E05.478.550.520.050.400]
      • Immunization Schedule [E05.478.550.545]
      • Immunization, Secondary [E05.478.550.550]
      • Immunotherapy, Active [E05.478.550.600]
        • Vaccination [E05.478.550.600.890]
          • Mass Vaccination [E05.478.550.600.890.500]
    • Immunologic Tests [E05.478.594]
      • Basophil Degranulation Test [E05.478.594.100]
      • Cell Migration Assays [E05.478.594.122]
        • Cell Migration Assays, Leukocyte [E05.478.594.122.500]
        • Cell Migration Assays, Macrophage [E05.478.594.122.750]
        • Skin Window Technique [E05.478.594.122.875]
      • Cytotoxicity Tests, Immunologic [E05.478.594.160]
        • Complement Hemolytic Activity Assay [E05.478.594.160.150]
      • Epitope Mapping [E05.478.594.280]
      • Hemolytic Plaque Technique [E05.478.594.375]
      • Histocompatibility Testing [E05.478.594.385]
        • Blood Grouping and Crossmatching [E05.478.594.385.120]
        • Lymphocyte Culture Test, Mixed [E05.478.594.385.429]
      • Immune Adherence Reaction [E05.478.594.400]
      • Immunoassay [E05.478.594.410]
        • Immunoblotting [E05.478.594.410.320]
          • Blotting, Western [E05.478.594.410.320.200]
            • Blotting, Far-Western [E05.478.594.410.320.200.200]
        • Immunoenzyme Techniques [E05.478.594.410.350]
          • Enzyme-Linked Immunosorbent Assay [E05.478.594.410.350.170]
            • Enzyme-Linked Immunospot Assay [E05.478.594.410.350.170.500]
          • Enzyme Multiplied Immunoassay Technique [E05.478.594.410.350.180]
        • Immunosorbent Techniques [E05.478.594.410.380]
          • Enzyme-Linked Immunosorbent Assay [E05.478.594.410.380.360]
            • Enzyme-Linked Immunospot Assay [E05.478.594.410.380.360.500]
          • Radioallergosorbent Test [E05.478.594.410.380.810]
          • Radioimmunoprecipitation Assay [E05.478.594.410.380.825]
          • Radioimmunosorbent Test [E05.478.594.410.380.830]
        • Radioimmunoassay [E05.478.594.410.639]
          • Immunoradiometric Assay [E05.478.594.410.639.405]
          • Radioallergosorbent Test [E05.478.594.410.639.810]
          • Radioimmunoprecipitation Assay [E05.478.594.410.639.825]
          • Radioimmunosorbent Test [E05.478.594.410.639.830]
      • Immunohistochemistry [E05.478.594.430]
        • Fluorescent Antibody Technique [E05.478.594.430.375]
          • Antibody-Coated Bacteria Test, Urinary [E05.478.594.430.375.050]
          • Fluorescent Antibody Technique, Direct [E05.478.594.430.375.300]
          • Fluorescent Antibody Technique, Indirect [E05.478.594.430.375.310]
          • Fluoroimmunoassay [E05.478.594.430.375.341]
            • Fluorescence Polarization Immunoassay [E05.478.594.430.375.341.350]
        • Immunoenzyme Techniques [E05.478.594.430.400]
          • Enzyme-Linked Immunosorbent Assay [E05.478.594.430.400.170]
            • Enzyme-Linked Immunospot Assay [E05.478.594.430.400.170.500]
          • Enzyme Multiplied Immunoassay Technique [E05.478.594.430.400.180]
      • Immunophenotyping [E05.478.594.450]
      • Leukocyte Adherence Inhibition Test [E05.478.594.500]
      • Lymphocyte Activation [E05.478.594.530]
      • Monitoring, Immunologic [E05.478.594.550]
      • Pregnancy Tests, Immunologic [E05.478.594.662]
      • Radioimmunodetection [E05.478.594.700]
      • Rosette Formation [E05.478.594.730]
      • Serologic Tests [E05.478.594.760]
        • Agglutination Tests [E05.478.594.760.050]
          • Hemagglutination Tests [E05.478.594.760.050.375]
            • Coombs' Test [E05.478.594.760.050.375.150]
          • Latex Fixation Tests [E05.478.594.760.050.450]
        • AIDS Serodiagnosis [E05.478.594.760.060]
        • Complement Fixation Tests [E05.478.594.760.150]
        • Complement Hemolytic Activity Assay [E05.478.594.760.155]
        • Hemadsorption Inhibition Tests [E05.478.594.760.360]
        • Hemagglutination Inhibition Tests [E05.478.594.760.370]
        • Neutralization Tests [E05.478.594.760.550]
        • Precipitin Tests [E05.478.594.760.645]
          • Flocculation Tests [E05.478.594.760.645.300]
          • Immunodiffusion [E05.478.594.760.645.350]
            • Immunoelectrophoresis [E05.478.594.760.645.350.350]
              • Counterimmunoelectrophoresis [E05.478.594.760.645.350.350.150]
              • Immunoelectrophoresis, Two-Dimensional [E05.478.594.760.645.350.350.350]
        • Radioallergosorbent Test [E05.478.594.760.830]
        • Radioimmunoprecipitation Assay [E05.478.594.760.840]
        • Serum Bactericidal Antibody Assay [E05.478.594.760.845]
        • Syphilis Serodiagnosis [E05.478.594.760.850]
          • Fluorescent Treponemal Antibody-Absorption Test [E05.478.594.760.850.200]
          • Treponema Immobilization Test [E05.478.594.760.850.800]
      • Serotyping [E05.478.594.780]
      • Skin Tests [E05.478.594.800]
        • Intradermal Tests [E05.478.594.800.300]
          • Kveim Test [E05.478.594.800.300.540]
          • Skin Test End-Point Titration [E05.478.594.800.300.750]
        • Local Lymph Node Assay [E05.478.594.800.450]
        • Passive Cutaneous Anaphylaxis [E05.478.594.800.600]
        • Patch Tests [E05.478.594.800.610]
        • Skin Window Technique [E05.478.594.800.705]
        • Tuberculin Test [E05.478.594.800.800]
    • Immunoprecipitation [E05.478.605]
      • Chromatin Immunoprecipitation [E05.478.605.160]
      • Precipitin Tests [E05.478.605.492]
        • Flocculation Tests [E05.478.605.492.300]
        • Immunodiffusion [E05.478.605.492.350]
          • Immunoelectrophoresis [E05.478.605.492.350.350]
            • Counterimmunoelectrophoresis [E05.478.605.492.350.350.150]
            • Immunoelectrophoresis, Two-Dimensional [E05.478.605.492.350.350.350]
      • Radioimmunoprecipitation Assay [E05.478.605.825]
    • Immunosuppression [E05.478.610]
      • Desensitization, Immunologic [E05.478.610.310]
      • Graft Enhancement, Immunologic [E05.478.610.500]
      • Lymphocyte Depletion [E05.478.610.570]
      • Transplantation Conditioning [E05.478.610.800]
  • Indicator Dilution Techniques [E05.484]
    • Dye Dilution Technique [E05.484.250]
    • Radioisotope Dilution Technique [E05.484.650]
    • Thermodilution [E05.484.750]
  • Interferometry [E05.490]
    • Microscopy, Interference [E05.490.630]
      • Microscopy, Phase-Contrast [E05.490.630.569]
    • Moire Topography [E05.490.815]
  • Intubation [E05.497]
    • Intubation, Gastrointestinal [E05.497.412]
    • Intubation, Intratracheal [E05.497.578]
      • Laryngeal Masks [E05.497.578.475]
  • Ischemic Preconditioning [E05.516]
    • Ischemic Preconditioning, Myocardial [E05.516.325]
  • Isotope Labeling [E05.522]
  • Manometry [E05.559]
    • Rhinomanometry [E05.559.740]
  • Materials Testing [E05.570]
  • Methods [E05.581]
    • Observation [E05.581.249]
    • Research Design [E05.581.500]
      • Control Groups [E05.581.500.149]
      • Double-Blind Method [E05.581.500.300]
      • Early Termination of Clinical Trials [E05.581.500.400]
      • Meta-Analysis as Topic [E05.581.500.501]
      • Patient Selection [E05.581.500.653]
      • Random Allocation [E05.581.500.805]
      • Sample Size [E05.581.500.902]
  • Microchip Analytical Procedures [E05.588]
    • Microfluidic Analytical Techniques [E05.588.465]
      • Electrophoresis, Microchip [E05.588.465.340]
    • Microarray Analysis [E05.588.570]
      • Oligonucleotide Array Sequence Analysis [E05.588.570.660]
      • Protein Array Analysis [E05.588.570.700]
      • Tissue Array Analysis [E05.588.570.850]
  • Micromanipulation [E05.591]
    • Microdissection [E05.591.560]
    • Microinjections [E05.591.570]
    • Microsurgery [E05.591.580]
  • Microscopy [E05.595]
    • Microscopy, Acoustic [E05.595.370]
    • Microscopy, Confocal [E05.595.395]
      • Laser Scanning Cytometry [E05.595.395.500]
    • Microscopy, Electron [E05.595.402]
      • Cryoelectron Microscopy [E05.595.402.150]
      • Electron Probe Microanalysis [E05.595.402.250]
      • Microscopy, Electron, Scanning [E05.595.402.541]
      • Microscopy, Electron, Transmission [E05.595.402.580]
        • Electron Microscope Tomography [E05.595.402.580.239]
        • Microscopy, Electron, Scanning Transmission [E05.595.402.580.480]
        • Microscopy, Energy-Filtering Transmission Electron [E05.595.402.580.500]
      • Microscopy, Immunoelectron [E05.595.402.625]
    • Microscopy, Fluorescence [E05.595.458]
      • Microscopy, Fluorescence, Multiphoton [E05.595.458.500]
    • Microscopy, Interference [E05.595.513]
      • Microscopy, Phase-Contrast [E05.595.513.569]
    • Microscopy, Polarization [E05.595.624]
    • Microscopy, Scanning Probe [E05.595.666]
      • Microscopy, Atomic Force [E05.595.666.400]
      • Microscopy, Scanning Tunneling [E05.595.666.500]
    • Microscopy, Ultraviolet [E05.595.680]
    • Microscopy, Video [E05.595.690]
    • Photomicrography [E05.595.799]
  • Models, Animal [E05.598]
    • Disease Models, Animal [E05.598.500]
      • Arthritis, Experimental [E05.598.500.249]
      • Diabetes Mellitus, Experimental [E05.598.500.374]
      • Liver Cirrhosis, Experimental [E05.598.500.468]
      • Neoplasms, Experimental [E05.598.500.496]
        • Leukemia, Experimental [E05.598.500.496.500]
        • Liver Neoplasms, Experimental [E05.598.500.496.750]
        • Mammary Neoplasms, Experimental [E05.598.500.496.843]
        • Melanoma, Experimental [E05.598.500.496.937]
        • Sarcoma, Experimental [E05.598.500.496.968]
      • Nervous System Autoimmune Disease, Experimental [E05.598.500.500]
        • Encephalomyelitis, Autoimmune, Experimental [E05.598.500.500.500]
        • Myasthenia Gravis, Autoimmune, Experimental [E05.598.500.500.750]
        • Neuritis, Autoimmune, Experimental [E05.598.500.500.875]
      • Radiation Injuries, Experimental [E05.598.500.750]
  • Models, Theoretical [E05.599]
    • Fractals [E05.599.125]
    • Fuzzy Logic [E05.599.250]
    • Models, Biological [E05.599.395]
      • Disease Models, Animal [E05.599.395.080]
      • Models, Cardiovascular [E05.599.395.161]
      • Models, Genetic [E05.599.395.397]
      • Models, Immunological [E05.599.395.500]
      • Models, Neurological [E05.599.395.642]
        • Neurolinguistic Programming [E05.599.395.642.550]
    • Models, Chemical [E05.599.495]
    • Models, Educational [E05.599.545]
    • Models, Molecular [E05.599.595]
      • Molecular Dynamics Simulation [E05.599.595.500]
    • Models, Nursing [E05.599.645]
    • Models, Organizational [E05.599.670]
    • Models, Psychological [E05.599.695]
      • Neurolinguistic Programming [E05.599.695.550]
    • Models, Statistical [E05.599.835]
      • Likelihood Functions [E05.599.835.500]
      • Linear Models [E05.599.835.750]
      • Logistic Models [E05.599.835.875]
      • Models, Economic [E05.599.835.890]
        • Models, Econometric [E05.599.835.890.500]
      • Nomograms [E05.599.835.895]
      • Proportional Hazards Models [E05.599.835.900]
    • Nonlinear Dynamics [E05.599.850]
  • Molecular Probe Techniques [E05.601]
    • Biosensing Techniques [E05.601.123]
      • Surface Plasmon Resonance [E05.601.123.700]
    • Blotting, Northern [E05.601.140]
    • Blotting, Southern [E05.601.150]
    • Blotting, Southwestern [E05.601.152]
    • Branched DNA Signal Amplification Assay [E05.601.300]
    • Immunoassay [E05.601.495]
      • Immunoblotting [E05.601.495.320]
        • Blotting, Western [E05.601.495.320.200]
          • Blotting, Far-Western [E05.601.495.320.200.500]
      • Immunoenzyme Techniques [E05.601.495.350]
        • Enzyme-Linked Immunosorbent Assay [E05.601.495.350.170]
          • Enzyme-Linked Immunospot Assay [E05.601.495.350.170.500]
        • Enzyme Multiplied Immunoassay Technique [E05.601.495.350.180]
      • Immunosorbent Techniques [E05.601.495.380]
        • Enzyme-Linked Immunosorbent Assay [E05.601.495.380.360]
          • Enzyme-Linked Immunospot Assay [E05.601.495.380.360.500]
        • Radioallergosorbent Test [E05.601.495.380.810]
        • Radioimmunoprecipitation Assay [E05.601.495.380.825]
        • Radioimmunosorbent Test [E05.601.495.380.830]
      • Radioimmunoassay [E05.601.495.639]
        • Immunoradiometric Assay [E05.601.495.639.405]
        • Radioallergosorbent Test [E05.601.495.639.810]
        • Radioimmunoprecipitation Assay [E05.601.495.639.825]
        • Radioimmunosorbent Test [E05.601.495.639.830]
    • Molecular Imaging [E05.601.567]
    • Oligonucleotide Array Sequence Analysis [E05.601.640]
    • Protein Array Analysis [E05.601.680]
    • Protein Interaction Mapping [E05.601.690]
      • Blotting, Far-Western [E05.601.690.149]
      • Epitope Mapping [E05.601.690.300]
      • Two-Hybrid System Techniques [E05.601.690.650]
    • Random Amplified Polymorphic DNA Technique [E05.601.700]
  • Neoplasm Transplantation [E05.624]
    • Xenograft Model Antitumor Assays [E05.624.850]
      • Subrenal Capsule Assay [E05.624.850.830]
  • Neuromuscular Blockade [E05.635]
  • Optical Tweezers [E05.650]
  • Oscillometry [E05.654]
  • Parabiosis [E05.660]
    • Cross Circulation [E05.660.365]
  • Perfusion [E05.680]
    • Reperfusion [E05.680.730]
      • Myocardial Reperfusion [E05.680.730.600]
  • Photography [E05.712]
    • Photography, Dental [E05.712.315]
    • Time-Lapse Imaging [E05.712.657]
  • Physical Conditioning, Animal [E05.718]
  • Physical Stimulation [E05.723]
    • Acoustic Stimulation [E05.723.136]
    • Electric Stimulation [E05.723.402]
      • Chronaxy [E05.723.402.201]
      • Electroshock [E05.723.402.403]
    • Photic Stimulation [E05.723.729]
  • Physiognomy [E05.734]
  • Preservation, Biological [E05.760]
    • Cryopreservation [E05.760.156]
      • Freeze Drying [E05.760.156.260]
        • Freeze Substitution [E05.760.156.260.270]
    • Refrigeration [E05.760.643]
    • Tissue Preservation [E05.760.833]
      • Blood Preservation [E05.760.833.230]
        • Blood Safety [E05.760.833.230.500]
      • Cold Ischemia [E05.760.833.445]
      • Organ Preservation [E05.760.833.660]
      • Semen Preservation [E05.760.833.890]
  • Prosthesis Fitting [E05.785]
  • Protein Refolding [E05.790]
  • Protein Unfolding [E05.793]
    • Protein Denaturation [E05.793.500]
  • Radiometry [E05.799]
    • Radiation Dosage [E05.799.513]
      • Dose-Response Relationship, Radiation [E05.799.513.500]
    • Radiation Monitoring [E05.799.638]
      • Body Burden [E05.799.638.231]
      • Film Dosimetry [E05.799.638.420]
      • Thermoluminescent Dosimetry [E05.799.638.785]
    • Radiometric Dating [E05.799.669]
    • Scintillation Counting [E05.799.700]
    • Spectrometry, Gamma [E05.799.801]
    • Spectrometry, X-Ray Emission [E05.799.830]
      • Electron Probe Microanalysis [E05.799.830.360]
    • Whole-Body Counting [E05.799.950]
  • Reproductive Techniques [E05.820]
    • Breeding [E05.820.150]
      • Estrus Detection [E05.820.150.360]
      • Estrus Synchronization [E05.820.150.370]
      • Hybridization, Genetic [E05.820.150.390]
      • Inbreeding [E05.820.150.520]
    • Cloning, Organism [E05.820.180]
    • Embryo Disposition [E05.820.240]
    • Fallopian Tube Patency Tests [E05.820.390]
    • Nuclear Transfer Techniques [E05.820.540]
    • Ovulation Detection [E05.820.690]
    • Ovulation Prediction [E05.820.745]
    • Reproductive Techniques, Assisted [E05.820.800]
      • Embryo Transfer [E05.820.800.500]
        • Single Embryo Transfer [E05.820.800.500.500]
      • Fertilization in Vitro [E05.820.800.750]
        • Sperm Injections, Intracytoplasmic [E05.820.800.750.700]
      • Gamete Intrafallopian Transfer [E05.820.800.875]
      • Insemination, Artificial [E05.820.800.937]
        • Insemination, Artificial, Heterologous [E05.820.800.937.515]
        • Insemination, Artificial, Homologous [E05.820.800.937.525]
      • Oocyte Donation [E05.820.800.968]
      • Oocyte Retrieval [E05.820.800.976]
      • Ovulation Induction [E05.820.800.984]
        • Superovulation [E05.820.800.984.500]
      • Posthumous Conception [E05.820.800.986]
      • Sperm Retrieval [E05.820.800.988]
      • Zygote Intrafallopian Transfer [E05.820.800.992]
  • Rheology [E05.830]
    • Hemorheology [E05.830.250]
    • Laser-Doppler Flowmetry [E05.830.500]
    • Lubrication [E05.830.583]
    • Microfluidics [E05.830.666]
      • Electrowetting [E05.830.666.500]
  • Analytic Sample Preparation Methods [E05.842]
  • Sonication [E05.848]
  • Sound Spectrography [E05.855]
  • Stem Cell Research [E05.864]
  • Stereotaxic Techniques [E05.873]
    • Neuronavigation [E05.873.249]
    • Radiosurgery [E05.873.500]
  • Substance Abuse Detection [E05.885]
  • Technology, Pharmaceutical [E05.916]
    • Click Chemistry [E05.916.079]
    • Combinatorial Chemistry Techniques [E05.916.160]
      • SELEX Aptamer Technique [E05.916.160.500]
    • Dosage Forms [E05.916.250]
    • Drug Compounding [E05.916.270]
    • Drug Incompatibility [E05.916.290]
    • Drug Labeling [E05.916.310]
    • Drug Packaging [E05.916.320]
    • Drug Stability [E05.916.330]
    • Drug Storage [E05.916.350]
    • Enzyme Stability [E05.916.360]
    • High-Throughput Screening Assays [E05.916.680]
  • Technology, Radiologic [E05.920]
    • Teleradiology [E05.920.700]
  • Telemetry [E05.925]
    • Remote Sensing Technology [E05.925.500]
  • Therapeutic Irrigation [E05.927]
    • Bronchoalveolar Lavage [E05.927.100]
      • Bronchoalveolar Lavage Fluid [E05.927.100.500]
    • Gastric Lavage [E05.927.441]
    • Nasal Lavage [E05.927.573]
      • Nasal Lavage Fluid [E05.927.573.500]
    • Peritoneal Lavage [E05.927.705]
    • Vaginal Douching [E05.927.852]
  • Toxicity Tests [E05.940]
    • Acute Toxicity Tests [E05.940.074]
      • Skin Irritancy Tests [E05.940.074.500]
    • Carcinogenicity Tests [E05.940.150]
    • Cytotoxicity Tests, Immunologic [E05.940.245]
    • Inhibitory Concentration 50 [E05.940.350]
    • Lethal Dose 50 [E05.940.402]
    • Maximum Tolerated Dose [E05.940.481]
    • Mutagenicity Tests [E05.940.560]
      • Comet Assay [E05.940.560.150]
    • No-Observed-Adverse-Effect Level [E05.940.600]
    • Toxicity Tests, Chronic [E05.940.800]
  • Trauma Severity Indices [E05.944]
    • Abbreviated Injury Scale [E05.944.250]
    • Glasgow Coma Scale [E05.944.500]
    • Glasgow Outcome Scale [E05.944.510]
    • Injury Severity Score [E05.944.600]
  • Wavelet Analysis [E05.959]
  • Weightlessness Countermeasures [E05.974]
  • Weightlessness Simulation [E05.977]
    • Hindlimb Suspension [E05.977.400]
  • Weights and Measures [E05.978]
    • Calibration [E05.978.155]
    • International System of Units [E05.978.507]
    • Metric System [E05.978.539]
    • Quartz Crystal Microbalance Techniques [E05.978.673]
    • Reference Standards [E05.978.808]
      • Fiducial Markers [E05.978.808.249]
      • Growth Charts [E05.978.808.500]
    • Reference Values [E05.978.810]
  • Whole Body Imaging [E05.979]
  • Whole-Body Irradiation [E05.980]